Moreover, we identified the target mRNAs of miR-126 and thus provided a novel mechanism of exosomal miR-126 associated with integrin alpha-6 (ITGA6) in NSCLC, aiming to supply an ideal biomarker for NSCLC diagnosis and treatment. The gene discussed is ITGA6; the disease is non-small cell lung carcinoma.